Trasylol Lawyers at Anapol Schwartz | Philadelphia Pennsylvania Attorneys at Law
  Do I have a Trasylol case? ... Contact us for a free consultation with one of our Trasylol Lawyers

About Trasylol

Heart Attack Risk after Heart Surgery

Bayer Suspends Trasylol Sales November 5, 2007

Benefits of Retaining Anapol Schwartz

Do you have a Trasylol case?

pdf guide

FDA Gets Trasylol Off the Market

BART Study Enrollment Ceases due to problems with Trasylol Safety.

Trasylol Wrongful Death Complaint

Do you have a NSF lawsuit?

Web Resources

Blog

 

About Trasylol

Contact us for a free legal consultation about your Trasylol Lawsuit


Aprotinin/Trasylol doubles the risk of kidney failure and stroke and increases the risk of heart failure or heart attack by 55 percent. Aprotinin/Trasylol is an injection used to prevent excessive blood loss during heart bypass surgery. Aprotinin is linked to encephalopathy, degenerative brain diseases. Are you or a family member eligible for an aprotinin lawsuit?


Please note Aprotinin is the generic word for the brand name Trasylol.

Why do hospitals use it? Maybe because Bayer funds hospital programs and research grants.

The generic alternatives Amicar (aminocaproic acid) and Cyklokapron (tranexamic acid) were studied too. These generic drugs were confirmed to be both safe and effective. Researchers estimated that if hospitals stopped using Trasylol and instead used the above generic drugs, it would save 9,000 to 11,000 people every year from kidney dialysis.

The difference in bypass surgery drugs is alarming:
Trasylol costs $1,300 per dose (manufactured by Bayer AG)
Amicar costs only $11 per dose (generic)
Cyklokapron costs $44 per dose (generic)

In January 2006, the New England Journal of Medicine wrote about a study revealing the dangerous Trasylol/aprotinin side effects. The maker of Trasylol, Bayer AG based in Germany, and its U.S. subsidiary with offices in suburban Pittsburgh, Pennsylvania, insisted that the study in the New England Journal of Medicine was flawed and that the Trasylol is safe.

Eight months later Bayer chose to not disclose the dangers of two recent aprontinin studies. On September 29, 2006 Bayer said it had mistakenly withheld another study based on 67,000 hospital patient records that suggested the drug could increase the chances of death, serious kidney damage, congestive heart failure, and stroke. Bayer only disclosed these serious facts after a whistleblower contacted the Food and Drug Administration (FDA).

And what’s really horrifying is that Bayer had been hoping that Trasylol would be used in all types of surgeries. Do you have a Trasylol/Aprotinin case?

Do you have a Trasylol/Aprotinin Lawsuit?

Do you need a Trasylol/aprotinin lawyer to fight for you? Do you have an unsafe aprotinin lawsuit? Isn’t it about time to consider the options?

PERSONAL INFORMATION



First Name:
Last Name:
E-mail Address:
Phone: () - ext.
Address:
City:
State:
Zipcode:
Date of birth of injured person:


TRASYLOL LAWSUIT INFORMATION

Date of surgery:
Have you (or injured party) experienced any of the following? (check all that apply)
Kidney failure
Stroke
Heart attack
Heart failure
Encephalopathy/brain disease
Death
Did you (or injured party) require dialysis? Yes No
Please describe the side effects you experienced:
Other information:

Copyright © 2004- - Anapol Schwartz - Pennsylvania Trasylol Lawyers Our Attorneys in Pennsylvania and New Jersey Trasylol Lawyers - Trasylol Class Action Law Firm. All rights reserved.

Trasylol Attorney Disclaimer:This website is dedicated to providing public information regarding Trasylol and other legal information. None of the information on this site is intended to be formal legal advice, nor the formation of a lawyer or attorney client relationship. Please contact a Pennsylvania Trasylol lawyer in Philadelphia - Ask a Trasylol attorney at our law firm for information regarding your particular case. This website is not intended to solicit clients outside the States of New Jersey and Pennsylvania.